08/23/2024
3:20 PM | Amgen (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13G/A | |
08/13/2024
4:44 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:41 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:43 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
6:00 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:23 PM | Amgen (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/04/2024
6:26 PM | Amgen (Issuer)
ECKERT ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/04/2024
6:27 PM | Amgen (Issuer)
Garland Greg C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:28 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:29 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:29 PM | Amgen (Issuer)
Jacks Tyler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:31 PM | Amgen (Issuer)
Klotman Mary E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:32 PM | Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:33 PM | Amgen (Issuer)
MILES AMY E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:22 PM | Amgen (Issuer)
Klotman Mary E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/04/2024
6:23 PM | Amgen (Issuer)
Austin Wanda M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:24 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
6:25 PM | Amgen (Issuer)
Druker Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:17 PM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
5:59 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:00 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:02 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:03 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:04 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:05 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:06 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:08 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:56 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:57 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:58 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:30 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:31 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:32 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:33 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:34 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:35 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
05/07/2024
7:37 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:39 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:25 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:48 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:17 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
6:18 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:19 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:20 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:22 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:24 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:25 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:59 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:00 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:01 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
7:44 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:50 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:50 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:51 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:53 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:54 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:55 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:04 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:05 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:07 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:09 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:10 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:11 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:12 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:59 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:00 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:34 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:25 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:26 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:27 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:29 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:30 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:32 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:23 PM | Amgen (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
6:50 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
10:35 AM | Amgen (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/19/2023
7:38 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2023
8:16 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
6:40 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
12/04/2023
6:41 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
7:44 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:30 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
1:11 PM | Amgen (Subject)
Graham Jonathan P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
7:06 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:09 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:10 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:12 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:15 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
